Federal contract receipt

$69,250,063 from Department of Health and Human Services to ELUSYS THERAPEUTICS INC

ANTHIM (OBILTOXAXIMAB)

Signals

Sole sourceNot competedLarge awardMulti-year performance

Office of Federal Procurement Policy

Public Spend Intelligence - sledai.com

Award #CONT_AWD_75A50324C00006_7505_-NONE-_-NONE-

Signed2024-05-14

PlaceNJ

ANTHIM (OBILTOXAXIMAB)

Total obligated$69,250,063.00

PoP Start

2024-05-01

PoP End

2027-04-30

SOLE SOURCE

Awarded on 2024-05-14